You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

先聲藥業(02096.HK)科賽拉新適應症上市申請獲受理

阿思達克 08-15 00:22
先聲藥業(02096.HK)公布，集團與G1合作的細胞週期蛋白依賴性激(酉每)CDK4/6抑制劑科賽拉(注射用鹽酸曲拉西利)新適應症上市申請獲中國國家藥品監督管理局受理，用於廣泛期小細胞肺癌患者在接受含拓撲替康方案治療前給藥，以降低化療引起的骨髓抑制的發生率。
先聲藥業(02096.HK)
Relevant Stocks
先聲藥業(02096.HK)
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.